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ABSTRACT
Bacterial vaginosis is characterized by a shift from the predominant lactobacillus vaginal flora to an
overgrowth of anaerobic bacteria. Bacterial vaginosis is associated with an increased risk of gyne-
cologic complications, including pelvic inflammatory disease, postoperative infection, cervicitis, hu-
man immunodeficiency virus (HIV), and possibly cervical intraepithelial neoplasia (CIN). The
obstetrical risks associated with bacterial vaginosis include premature rupture of membranes, pre-
term labor and delivery, chorioamnionitis and postpartum endometritis. Despite the health risks
associated with bacterial vaginosis and its high prevalence in women of childbearing age, bacterial
vaginosis continues to be largely ignored by clinicians, particularly in asymptomatic women. Infect.
Dis. Obstet. Gynecol. 8:184-190, 2000. (C) 2000Wiley-Liss, Inc.
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acterial vaginosis (BV) is the most .common
}vaginal infection among women of childbearing
age. 1-4 BV occurs in 33% to 36% of women attend-
ing sexually transmitted disease clinics, 16% to
20% of pregnant women, and in up to 25% of
women attending gynecologic clinics,s-9 Thus, rou-
tine screening and prompt treatment ofBV in these
populations may be critical in certain clinical sce-
narios.
BV is characterized by a disruption in the vagi-
nal flora whereby anaerobic bacteria, Mycoplasma
hominis and Gardnerella vaginalis overgrow at the
expense of protective lactobacilli. Although the
exact cause of bacterial vaginosis is unknown,
predisposing factors include douching, previous
sexually transmitted disease, a change in sexual
partner, and use of intrauterine devices.9-11 High
prevalence rates have been reported in patients
attending sexually transmitted disease clinics,
yet BV has been noted in virginal women as
well.11,z
The most common outward symptoms of BV
include a thin, homogeneous, milky white or dull
gray vaginal discharge, a foul or fishy odor that may
intensify following sexual intercourse, and some-
times vaginal burning or itching. However, as many
as 50% of all women with BV are asymptomatic.
13
Therefore, it is critical that patients are educated
about BV and routinely screened for this infection.
Clinically, bacterial vaginosis is diagnosed by the
presence of three of the following four criteria: a
vaginal pH of greater than 4.5, the presence of clue
cells in the vaginal fluid, a thin, white or gray ho-
mogeneous vaginal discharge, or a positive KOH
whiff testmthe release of an amine (fishy) odor
upon the addition of 10% potassium hydroxide to
the vaginal fluid.3 Use of Gram stain is an alter-
native using the Nugent criteria for the diagnosis of
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BV. 14 It has been shown to correlate well with clini-
cal criteria and is an effective way to screen for
asymptomatic BV. However, because Gram stain
can be logistically more difficult due to the need
for laboratory evaluation, the majority of practitio-
ners use wet mount to detect the presence of clue
cells, pH tests, and "whiff" tests.
While BV was once thought to be merely a nui-
sance condition, more recent investigations have
demonstrated that it is associated with an increased
risk of gynecologic and obstetric complications.
Gynecologic conditions associated with BV include
pelvic inflammatory disease, ls,6 postoperative in-
fection such as postabortion endometritis7,8 and
pelvic cuff cellulitis following hysterectomy,9,z
cervicitis, el human immunodeficiency virus
(HIV),zz-z4 and possibly cervical intraepithelial
neoplasia (CIN).zs The obstetrical risks associated
with BV include premature rupture of membranes,
preterm labor and delivery, 7 chorioamnionitis,z6
and postpartum endometritis,z6
Despite its prevalence and associated health
risks, bacterial vaginosis remains underdiagnosed
by clinicians and poorly understood by patients.
Research by Wiesenfeld and Macioz7 found that
three of the four standard diagnostic procedures for
bacterial vaginosis were not routinely performed to
evaluate women with vulvovaginal symptoms. Of
150 office visits with 50 different physicians, 58%
routinely performed microscopy, while pH and
whiff tests were performed by only 2% and 8% of
physicians, respectively.
Low patient awareness of BV is suggested by
two recent surveys. In a 1993 Gallup survey of
1,011 women aged 18 years or older, 64% of re-
spondents reported that they had never heard of
bacterial vaginosis,z8 Similarly, a 1998 survey of 301
women aged 18-50 who reported having at least
one vaginal infection in the previous three years,
determined that 80% of the respondents could not
identify the symptoms of bacterial vaginosis,z9
Given the health risks associated with bacterial
vaginosis, low patient awareness combined with
poor diagnostic practice may have significant im-
plications for the female patient. While much of
the recent literature has focused on obstetrical
complications, greater emphasis should be placed
on the non-pregnant patient for whom gynecologic
health risks pose the greatest threat. Indeed, bac-
terial vaginosis is believed to be the cause of one-
third to one-half of all infectious vaginal condi-
tions,s Moreover, because non-pregnant women
represent the majority of BV cases, many of whom
may be asymptomatic, routine screening and
prompt treatment in this population is critical. This
article will discuss the pathogenesis of BV and re-
view the literature documenting the link between
BV and several of the most common gynecologic
conditions.
ETIOLOGY OF BV: A NATURAL LINK TO
GENITAL TRACT COMPLICATIONS
Though the etiology of bacterial vaginosis is not
completely understood, research has confirmed
that BV is a synergistic, polymicrobial infection
characterized by a shift in the bacterial flora of the
vagina. Normal vaginal flora consists predomi-
nantly of lactobacilli, though both aerobic and an-
aerobic bacteria also can be found in small num-
bers. Lactobacilli serve as a natural host defense by
producing both lactic acid, which maintains the
vaginal pH below 4.5, and hydrogen peroxide,
which inhibits the growth of non-catalase-
producing microorganisms,z6 This combination
creates a potent defense against the overgrowth of
other vaginal bacteria, particularly anaerobes,z6
In women with BV, the concentration of lacto-
bacilli is significantly reduced (fewer than 10,000
colonies/ml of vaginal fluid) allowing for the over-
growth of anaerobes, Gardnerdla vaginalis and My-
coplasma hominis, which prevail in numbers 100 to
1000 times higher than in women with normal
flora,z6 In particular, G. vaginalis, Peptostreptococcus
spp., Prevotdla spp., and Mobiluncus spp. are pres-
ent in increased numbers in women with BV.
Due to the proximity and permeability of the
lower and upper genital tract mucosa, a dominance
of pathogens in the vagina places women with BV
at higher risk for upper genital tract infection,z6 In
addition, enzymes and metabolic byproducts of ab-
normal vaginal flora impede normal white blood
cell response to infection.e Specifically, BV has
been implicated in the gynecologic conditions dis-
cussed below.
POSTOPERATIVE INFECTION
Postoperative infection continues to be a common
complication of gynecologic surgery. Specifically,
pelvic inflammatory disease (PID) following first-
trimester abortion and pelvic cellulitis following
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abdominal hysterectomy are particularly prevalent.
The incidence of PID following first-trimester
abortion is 4% to 12% and postoperative pelvic cel-
lulitis occurs in up to 70% of patients undergoing
hysterectomy without prophylaxis. 1s,3 Research
has identified bacterial vaginosis as a risk factor for
development of both of these conditions.
Postabortion Endometritis/PID
The presence of Mobiluncus and clue cells in vagi-
nal smears has been clinically correlated with bac-
terial vaginosis. In a study by Larsson et al., 17
women in whom Mobiluncus and clue cells were
detected were found to have a higher risk of posta-
bortion pelvic inflammatory disease than women
without presence of these organisms. Women in
this study also were examined for C. trachomatis,
which previously has been identified as a risk factor
for PID.
Mobilucus were identified in specimens from 81
women (15.2%), while C. trachomatis presented in
specimens from 39 women (7.6%). A combination
of Mobilucus and C. trachomatis was detected in 11
cases. In women where Mobiluncus had been seen,
the incidence of PID was 10.8%, compared with
4.5% of women with neither Mobilucus nor C. tra-
chomatis.
Additionally, clue cells were detected in 65 of
the 198 (32.8%) Gram-stained smears, while 133
(67.2%) indicated normal epithelium cells. The in-
cidences of PID in these groups were 11.8% and
3.2% respectively (P 0.01). Moreover, women
identified with C. trachomatis were younger than
the rest of the study population, indicating two
possible risk groups for developing PID after first-
trimester abortion.
Further research by Larsson et al. 18 confirms an
association between BV and postabortion pelvic in-
flammatory disease, and underscores the benefits
of prophylactic therapy. In a double-blind, random-
ized placebo-controlled study of 231 women under-
going first-trimester abortion and fulfilling the cri-
teria for BV, subjects were randomized to receive
either 500 mg of metronidazole three times daily or
placebo for ten days. Women with C. trachomatis
infection were excluded from the study group.
Among the 174 women who could be evaluated,
pelvic inflammatory disease developed in three
women in the treatment group (3.6%) compared to
11 (12.2%) in the placebo group (P < 0.05). Thus,
treatment with metronidazole in women with bac-
terial vaginosis undergoing first-trimester abortion
resulted in a threefold reduction in the rate of post-
operative pelvic inflammatory disease.
Postabortion pelvic inflammatory disease was
defined as two or more of the following six criteria
fulfilled within 28 days of the surgery: (1) abnormal
or purulent vaginal discharge after week, (2) ab-
normal bleeding after the third day, (3) tempera-
ture > 38.0C (100.4F) for > 24 hours, (4) palpable
adnexal masses, (5) tenderness over the uterus or
adnexa on pelvic examination, or (6) erythrocyte
sedimentation rate > 30 mm.
Posthysterectomy Infection/Pelvic Cuff
Cellulitis/Postcesarean Endometritis
A study by Soper et al. 19 found that women with
bacterial vaginosis had a three times higher risk of
developing cuff cellulitis, cuff abscess, or both fol-
lowing abdominal hysterectomy than women with-
out BV (relative risk 3.2, 95% confidence interval
1.5 to 6.7). Moreover, organisms associated with BV
including G. vaginalis, Bacteroides spp., or Peptostrep-
tococcus spp. were isolated from the vaginal cuff of
more than 60% of cases of cuff ccllulitis.9 Cuff
cellulitis was defined by persistent fever on two
occasions, excluding the first 48 hours postsurgery,
in association with increased vaginal cuff tender-
ness and induration on bimanual pelvic examina-
tion. Cuff abscess was diagnosed in patients meet-
ing the criteria for cuff cellulitis, who also had a
palpable, fluctuant mass located superior to the va-
gina.
These findings were confirmed by Larsson ct al.
In their study of 70 women scheduled for abdomi-
nal hysterectomy, 7 of 20 women (35%) with BV, as
identified by the presence of clue cells in the vagi-
nal discharge, developed vaginal cuff infections,
versus 4 of 50 women (8%) without clue cells,z
Vaginal cuff infections were defined by the pres-
ence of at least two of the following: temperature
higher than 38C after the third postoperative day,
foul-smelling discharge, or increasing abdominal
pain after the second postoperative day. Impor-
tantly, none of the patients in this study or in the
aforementioned Soper study received antibiotic
prophylaxis.
More recently, Lin et al. conducted a prospec-
tive study, which looked at both intermediate and
definite stages of BV as potential risk factors for
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postoperative infection following gynecologic sur-
gery. In this study, 175 women undergoing major
gynecologic surgery, which included benign gyne-
cologic, urogynecologic, and gynecologic oncology
cases, were evaluated for the presence of BV based
on Nugent’s criteria. The criterion for positive-BV
was a score of 7 or higher, while intermediate BV
was defined by a score of 4 to 6. Lactobacillus-
predominant flora was defined by a score of 0 to 3.
Thirty-six percent of the positive-BV group devel-
oped a postoperative fever, compared with 20% of
the Lactobacillus-predominant group and 12% of
the intermediate-BV group (P 0.017). The differ-
ence between the positive-BV group and the inter-
mediate-BV group was statistically significant (P
0.045 and P 0.007, respectively), while the dif-
ference between the intermediate-BV group and
the Lactobacillus-predominant group was not.
Research identifying bacterial vaginosis as a risk
factor for postcesarean endometritis was conducted
by Watts et al.3z in 1990 and by Sanchez-Ramos et
al.3 in 1999. Watts et al. found that women with
bacterial vaginosis, as diagnosed by Gram stain,
were approximately six times more likely to de-
velop postcesarean endometritis than women with
normal vaginal flora.3z Postpartum endometritis
was diagnosed in 34 (35%) of the 97 patients with
bacterial vaginosis compared with 35 (10%) of the
365 women with normal flora (P < 0.001), despite
the use of antibiotic prophylaxis.3z
In an additional study presented at the Society
of Maternal Fetal Medicine in early 1999, Sanchez-
Ramos et al. looked at treating pregnant women,
at least 24-weeks gestation, prior to cesarean sec-
tion with topical metronidazole or placebo. An in-
terim analysis of this double-blinded trial showed
that 6% of women treated with topical metronida-
zole developed postcesarean endometritis versus
28% of patients who received placebo gel (P
0.04). The authors also noted that patients receiv-
ing placebo required a more prolonged postpartum
stay.
3
Based on the significant body of evidence link-
ing BV with postsurgical infection, preoperative
screening for and treatment of BV is recom-
mended.
PELVIC INFLAMMATORY DISEASE
Pelvic inflammatory disease, which refers to in-
flammation of the upper genital tract, includes any
one or a combination of the following conditions:
endometritis, salpingitis, pelvic peritonitis, or tubo-
ovarian abscess. Though the exact etiology of PID
is not completely understood, it is believed to oc-
cur by the ascension of microorganisms from the
vagina or endocervix to the endometrium and fal-
lopian tubes.4 A significant body of research dem-
onstrates that the presence of bacterial vaginosis-
associated organisms is strongly associated with the
development of pelvic inflammatory disease.
Soper et al. found that bacterial vaginosis was
present in 62% of patients with confirmed acute
salpingitis (n 84). 16 Moreover, 100% of the an-
aerobes isolated from the upper genital tract of
these women were microorganisms found in bacte-
rial vaginosis.
Findings by Hillier et al. support these results.4
They found that high concentrations of pathogenic
microorganisms, most frequently those associated
with bacterial vaginosis including G. vaginalis, an-
aerobic Gram-negative rods, Peptostreptococcus spp.,
and M. hominis, were recovered from the endome-
tria of 94% of women with histologic endometritis
(n 117). Similarly, bacterial vaginosis-associated
organisms were detected in the fallopian tubes or
peritoneal fluid of more than half (55%) of the pa-
tients. Furthermore, Hillier et al. clearly demon-
strated that presence of BV-associated organisms is
associated with plasma cell endometritis even after
controlling for Chlamydia and Neisseria gonorrhoeae.
In a study by Korn et al.,s plasma cell endome-
tritis was frequently observed in women with bac-
terial vaginosis. Plasma cell endometritis was noted
in 10 of the 22 patients (45%) with BV, versus of
19 (5%) women in the control group (P < 0.01).
Furthermore, bacterial vaginosis-associated organ-
isms were elicited from the endometria of 9 of 11
women with plasma cell endometritis and 8 of the
30 women without plasma cell endometritis (P
0.002).
Recent research by Peipert et al. further docu-
ments the association between BV and upper geni-
tal tract infection,s6 In their study of 116 women
meeting the minimal criteria of the Centers for
Disease Control and Prevention for acute pelvic
inflammatory disease or with other "nonclassic"
signs of upper genital tract infection (e.g., atypical
pelvic pain or abnormal uterine bleeding), object
evidence of upper genital tract infection was pres-
ent in 56% (14/25) of women with the clinical
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diagnosis of bacterial vaginosis compared with 30%
of women (27/91) who did not meet the clinical
criteria. The presence of BV was associated with a
threefold increased risk of upper genital tract in-
fection. The objective criteria used for diagnosis of
upper genital tract infection included histologic en-
dometritis or salpingitis, laparoscopic evidence of
salpingitis, or microbiologic evidence of N. gonor-
rhea or C. trachomatis from the endometrium or fal-
lopian tubes.
CERVICITIS
It is estimated that as many as one-half of women
attending sexually transmitted disease (STD) clin-
ics with clinically defined cervicitis have coexisting
BV.el A direct link between the two disease states
is demonstrated in findings by Schwebke et al. who
reported that cervicitis did not respond to recom-
mended treatment unless coexisting BV was
treated,el In their pilot study of women with coex-
istent BV and cervicitis attending an STD clinic,
patients were treated in two phases. During phase
I, women were treated with doxycycline alone; in
phase II, patients were treated with both doxycy-
cline and intravaginal metronidazole gel. Results
showed 86% ofwomen who were treated concomi-
tantly with doxycycline and metronidazole gel had
clinical resolution of their cervicitis, compared with
53% ofwomen who did not receive the intravaginal
metronidazole,z
HUMAN IMMUNODEFICIENCY VIRUS
As the proportion ofwomen acquiring HIV through
heterosexual transmission continues to increase,
emerging research demonstrates an association be-
tween abnormal vaginal flora and increased suscep-
tibility to HIV. Data from several large-scale stud-
ies suggests a potential role for BV in HIV
transmission.
One of the first clinical studies to demonstrate
the association between bacterial vaginosis and
HIV was conducted by Cohen et al.z4 This cross-
sectional study of 144 commercial sex workers in
Thailand reported a clinical diagnosis of BV in 47%
of the HIV-positive women compared with 24% of
the HIV-negative women--a fourfold increase in
the risk ofBV in the HIV group after accounting for
other variables.
In a prevalence study of 4,718 pregnant women
in rural Uganda, 27% of women with severe bacte-
rial vaginosis had HIV, whereas 14% of women
with normal vaginal flora had HIV(P < 0.0001).
Women with HIV had a 50% increased prevalence
of moderate BV (Gram stain score 7 to 8) and a
110% increased prevalence of more severe BV
(Gram stain score 9 to 10) after controlling for se-
lected other infections,zz
A 1998 trial of 1,196 pregnant women in Malawi
demonstrated for the first time that a woman’s risk
of acquiring HIV increased in direct proportion to
the severity of bacterial disturbances in the vagina.
Women with severe bacterial vaginosis were 3.7
times more likely to acquire HIV than women
without BV.z3
Most recently, a 1999 study by Taha et al. pro-
vides further support for an association between
bacterial vaginosis and prevalence of HIV infec-
tion.37 In two cross-sectional studies conducted
among pregnant women in urban Malawi the
prevalence of HIV-1 was 23% and 30% in 1990 and
1993, respectively. Overall, 30% of women with
HIV also presented with BV, as diagnosed by Am-
sel’s criteria. Furthermore, 59% had mild or mod-
erate disturbances in vaginal flora (indicated by the
presence of one and two of Amsel’s criteria, respec-
tively), while only 11% had normal flora.
CERVICAL INTRAEPITHELIAL NEOPLASIA
Cervical intraepithelial neoplasia and cervical can-
cer are major causes of morbidity and mortality
among women. It has been suggested that bacterial
vaginosis could be important in the development of
CIN.
Scandinavian studies have shown good correla-
tion between clue cells on Pap and BV. Davis et al.
recently reported that Pap smear had a specificity
of 98% and a positive predictive value of 96% in
the diagnosis of BV versus Gram stain.s
In a study by Platz-Christensen et al.zs to inves-
tigate the association between the presence of clue
cells in PAP smears and CIN, CIN occurred in 5%
of women with BV versus 1.4% of women without
BV. The relative risk for having any CIN was 8.0 if
bacterial vaginosis was present (95% confidence in-
terval 4.1-15.6) and the relative risk for having CIN
III/CIS was 5.0 if BV was also present,es
Findings by Eltabbakh et al. further support an
association between bacterial vaginosis and abnor-
mal cytology.9 Their research found that 50% of
963 asymptomatic women presenting for an annual
188 INFECTIOUS DISEASES IN OBSTETRICS AND GYNECOLOGYBACTERIAL VAGINOSIS SWEET
Pap smear also had a vaginal and/or cervical infec-
tion, the most prevalent of which was bacterial vag-
inosis, which presented in 28% of patients. Fur-
thermore, a diagnosis of BV on wet mounts was
associated with inflammation and atypical cells in
Pap smears in 50% of cases.
Further studies are required to verify if an asso-
ciation between BV and CIN exists. Whether BV is
related to development of CIN as a cofactor with
human papillomavirus or produces inflammation
obscuring accurate Pap smear interpretation is yet
unclear.
CONCLUSION
A substantial body of research has confirmed the
association between bacterial vaginosis and various
gynecologic conditions, some of which have poten-
tially serious implications for the non-pregnant pa-
tient. Currently, treatment is the only method cli-
nicians have to positively effect the vaginal flora.
The recommended treatments consist of both topi-
cal and oral metronidazole or clindamycin. They all
have been shown to be equally efficacious at treat-
ing BV, although there are differences in systemic
absorption, side effects, convenience, and patient
acceptance. Given the potential for bacterial vagi-
nosis to greatly impact a woman’s reproductive and
overall health, clinicians should place greater em-
phasis on maintaining a healthy vaginal flora in
their gynecologic patients. This may be accom-
plished through more frequent screening for and
prompt treatment of bacterial vaginosis.
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